Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the standard first line treatment for advanced non-small cell lung cancer (NSCLC) with sensitive EGFR mutations. Among NSCLC, giant cell carcinoma of the lung (GCCL) is a rare pathological subtype with poor prognosis, with n...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Weng, Shan-Shan, Cao, Ying, Tang, Xiu-Jun, Zhu, Li-Zhen, Tan, Yi-Nuo, Dong, Cai-Xia, Chen, Jia-Qi, Shen, Hong, Yuan, Ying
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2017
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421933/
https://ncbi.nlm.nih.gov/pubmed/28445978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15831
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items